Hydrozid is a portable aerosol cryosurgical device for the treatment of benign and precancerous skin lesions. It uses the medically approved gas norflurane as a cryogen, which is non-toxic, non-flammable and does not harm the ozone layer. Key features: safety: Hydrozide can be used without protective equipment and does not require special storage conditions; efficacy: provides rapid and effective treatment of a wide range of skin lesions such as warts, seborrhoeic keratosis, actinic keratosis, skin tags, etc.; ease of use: ready-to-use without additional preparation, easily controlled by a direct spray on the lesion; cost-effectiveness: does not require a large initial investment, has a long shelf life of 3 years and can be disposed of as normal waste. Hydrozide is approved for use in Europe and the USA for professional use in the treatment of a wide range of skin lesions. Information leaflet More information
